{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:43:54Z","timestamp":1789577034699,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012446","name":"Akershus University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcv.2020.104336","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:06:00Z","timestamp":1589191560000},"page":"104336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework"],"prefix":"10.1016","volume":"128","author":[{"given":"Ditte M\u00f8ller","family":"Ejegod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Kraus","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4853-6747","authenticated-orcid":false,"given":"Jesper","family":"Bonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2020.104336_bib0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jcv.2020.104336_bib0010","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: A protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2020.104336_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2018.09.012","article-title":"The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium","volume":"108","author":"Bonde","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2020.104336_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12985-018-1076-6","article-title":"Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening","volume":"15","author":"Akbari","year":"2018","journal-title":"Virol J"},{"key":"10.1016\/j.jcv.2020.104336_bib0025","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JCM.00897-16","article-title":"Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)","volume":"54","author":"Cuschieri","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0030","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/JCM.01366-15","article-title":"Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework","volume":"53","author":"Cuschieri","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0035","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JCM.01962-14","article-title":"Clinical evaluation of a GP5+\/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control","volume":"52","author":"Geraets","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcv.2016.05.004","article-title":"Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework","volume":"81","author":"Heard","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2020.104336_bib0045","article-title":"Clinical and analytical evaluation of the Anyplex II HPV HR Detection assay within the VALGENT-3 framework","author":"Ostrbenk","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01282-17","article-title":"Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel","author":"Polman","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0055","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/ijc.27891","article-title":"Prevalence and viral load of 51 genital human papillomavirus types and three subtypes","volume":"132","author":"Schmitt","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2020.104336_bib0060","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1128\/JCM.00087-13","article-title":"Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities","volume":"51","author":"Schmitt","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1055-9965.EPI-12-1067","article-title":"Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions","volume":"22","author":"Schmitt","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2020.104336_bib0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2018.09.005","article-title":"Validation of EUROArray HPV test using the VALGENT framework","volume":"108","author":"Viti","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2020.104336_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcv.2017.12.001","article-title":"Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework","volume":"98","author":"Xu","year":"2018","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2020.104336_bib0080","first-page":"19","article-title":"Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework","author":"Xu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcv.2020.104336_bib0085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jcv.2020.104336_bib0090","first-page":"54","article-title":"HPV assays validated for primary screening","author":"Arbyn","year":"2018","journal-title":"HPV world"},{"key":"10.1016\/j.jcv.2020.104336_bib0095","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/JCM.05552-11","article-title":"Clinical validation of the cobas 4800 HPV test for cervical screening purposes","volume":"49","author":"Heideman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0100","series-title":"Cobas HPV test","author":"FDA","year":"2015"},{"key":"10.1016\/j.jcv.2020.104336_bib0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jmoldx.2016.10.003","article-title":"Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid","volume":"19","author":"Krevolin","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jcv.2020.104336_bib0110","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/sim.1213","article-title":"On tests of equivalence via non-unity relative risk for matched-pair design","volume":"22","author":"Tang","year":"2003","journal-title":"Stat Med"},{"issue":"Suppl 5","key":"10.1016\/j.jcv.2020.104336_bib0115","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2020.104336_bib0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12905-019-0743-0","article-title":"HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system","volume":"19","author":"Frayle","year":"2019","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jcv.2020.104336_bib0125","first-page":"57","article-title":"Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening","author":"Saville","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0130","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"issue":"184","key":"10.1016\/j.jcv.2020.104336_bib0135","first-page":"e1","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcv.2020.104336_bib0140","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"46","key":"10.1016\/j.jcv.2020.104336_bib0145","first-page":"e1","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcv.2020.104336_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jcv.2020.104336_bib0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcv.2020.104336_bib0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcv.2020.104336_bib0165","doi-asserted-by":"crossref","first-page":"e59765","DOI":"10.1371\/journal.pone.0059765","article-title":"Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay","volume":"8","author":"Preisler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2020.104336_bib0170","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086835","article-title":"Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening","volume":"9","author":"Rebolj","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2020.104336_bib0180","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cmi.2017.12.001","volume":"24","author":"de Thurah","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jcv.2020.104336_bib0185","article-title":"Clinical and analytical performance of the BD Onclarity HPV Assay with SurePath screening samples from the Danish cervical screening program using the VALGENT framework","author":"Bonde","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2020.104336_bib0190","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/14737159.2019.1613890","article-title":"Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studies","volume":"19","author":"Xu","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jcv.2020.104336_bib0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/M15-2735","article-title":"Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis","volume":"166","author":"Arbyn","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcv.2020.104336_bib0200","article-title":"Triaging HPV positive women with normal cytology or low grade dyskaryosis: evidence from 10 year follow-up of the ARTISTIC trial cohort","author":"Gilham","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.jcv.2020.104336_bib0205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41416-019-0547-x","article-title":"16\/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot","volume":"121","author":"Rebolj","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcv.2020.104336_bib0210","article-title":"Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review","author":"Bonde","year":"2019","journal-title":"J Low Genit Tract Dis"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220300780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653220300780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:12:48Z","timestamp":1761361968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653220300780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":42,"alternative-id":["S1386653220300780"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104336","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2020.104336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104336"}}